Incendia Therapeutics Adds Louis G. Lange, M.D., Ph.D., To Board
11 Dec 2024 //
BUSINESSWIRE
Incendia Therapeutics Appoints Bradford Smith as CFO
03 Dec 2024 //
BUSINESSWIRE
DELFI Diagnostics Partners with Incendia on Phase 1 Trial
28 Oct 2024 //
PR NEWSWIRE
XtalPi and Parthenon Enter Into AI-Powered Antibody Discovery Partnership
05 Sep 2023 //
PR NEWSWIRE
Parthenon Announces Publication in Journal for ImmunoTherapy of Cancer PRTH-101
22 Jun 2023 //
BUSINESSWIRE
Parthenon Announces Publication in Journal for ImmunoTherapy of Cancer
12 Jun 2023 //
BUSINESSWIRE
Parthenon Announces First Patient Dosed in Phase 1 Clinical Trial of PRTH-101
25 Apr 2023 //
BUSINESSWIRE